N. Ndabambi

Combining Viral Genetics and Statistical Modeling to Improve HIV-1 Time-of-Infection Estimation towards Enhanced Vaccine Efficacy Assessment

Simon A. A. Travers, Lindsay N. Carpp, J. P. Labuschagne, 2019, Viruses.

Early evolution of HLA-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C infected women.

C. Gray, S. Karim, N. Garrett, 2017 .

Early evolution of human leucocyte antigen-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C-infected women

C. Gray, N. Garrett, C. Williamson, 2017, AIDS.

Replication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression

N. Garrett, C. Williamson, P. Selhorst, 2017, Journal of Virology.

No Evidence for Selection of HIV-1 with Enhanced Gag-Protease or Nef Function among Breakthrough Infections in the CAPRISA 004 Tenofovir Microbicide Trial

Jaclyn K. Mann, S. Omarjee, T. Ndung’u, 2013, PloS one.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

False-negative HIV-1 polymerase chain reaction in a 15-month-old boy with HIV-1 subtype C infection.

B. Eley, C. Williamson, S. Korsman, 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape

J. Mascola, D. Burton, M. Connors, 2017, PLoS pathogens.

Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide

J. Carlson, C. Williamson, S. A. Abdool Karim, 2017, Journal of acquired immune deficiency syndromes.

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

Allan C. deCamp, Dylan H. Westfall, J. Mullins, 2023, PLoS pathogens.